SEARCH RESULTS

71 RESULTS

John Hardy on Aducanumab Approval Sparks Backlash

COMMENT I think aducanumab had a small beneficial effect on mildly affected individuals. This opinion is weakly held, and I respect the opinion of those who disagree. We await further data for sure, as this did not reach the threshold of “beyond a reasonable ...

John Hardy on With PLD3, Forget APP...Think Lysosome Instead

COMMENT This paper from the De Strooper lab convincingly shows that there is not a clear effect of PLD3 on APP biology and reignites the debate on whether PLD3 is an AD gene (Cruchaga et al., 2013). Genetic analysis looking for rare variants is subject to ...

Current Filters

  • TYPE: Comment x
  • Commentator: Hardy, John x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE